Mobile

A Phase 2 multi-center, open label, long-term extension trial to assess the safety of oral UK-390,957 administered as required in adult men with premature ejaculation

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-003737-13

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the long-term safety and tolerability of oral UK-390,957 administered to adult men with premature ejaculation who have successfully completed 1 of the Pfizer trials A3871022, A3871027 or A3871029.

Critère d'inclusion

  • premature ejaculation

Liens